← Back
Data updated: Jun 28, 2026
NEW RIVER
Specialty Pharmaceuticals
NEW RIVER is a specialty pharmaceutical company with 7 FDA-approved products.
1965
Since
7
Drugs
-
Trials
0
New Drugs (2yr)
NEW RIVER's Key Drugs
NEW RIVER's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
NEW RIVER's Recent FDA Approvals
New NDA/BLA approvals for NEW RIVER over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
NEW RIVER's Therapeutic Areas
Disease areas where NEW RIVER has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
NEW RIVER Pipeline Snapshot
Active clinical trials for NEW RIVER across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1965-08-23
- Latest
- 2009-03-13
- Applications
- 3